Table 3.
Clinical Characteristics Of Cancer Patients With VTE (n = 186) (Incidence 1.1% Of Total Cancer Patients)
| Total | Whites | Blacks | p-value | Other ✝ | p-value | |
|---|---|---|---|---|---|---|
|
| ||||||
| Patient, n (%) | 186 (100) | 52 (27.96) | 97 (52.15) | 37 (19.89) | ||
| Incidence of VTE (%) | 186/16498 (1.1) | 52/9060 (0.6) | 97/5498 (1.8) | <0.001 | 37/1940 (1.9) | <0.001 |
| Mean age, years (SD) | 63.65 (13.03) | 62.38 (12.86) | 65.79 (13.25) | 0.133 | 59.66 (11.74) | 0.318 |
| Sex, n (%) | 0.515 | 0.982 | ||||
| Men | 105 (56.5) | 31 (59.6) | 51 (52.6) | 23 (62.2) | ||
| Women | 81 (43.5) | 21 (40.4) | 46 (47.4) | 14 (37.8) | ||
| BMI (SD) | 26.73 (7.20) | 27.91 (6.88) | 26.04 (7.6) | 0.144 | 26.88 (6.49) | 0.117 |
| Stage, n (%) | 0.592 | 0.433 | ||||
| I | 15 (8.1) | 6 (11.5) | 7 (7.2) | 0.416 | 2 (5.4) | 0.594 |
| II | 33 (17.7) | 11 (21.2) | 17 (17.5) | 0.533 | 5 (13.5) | 0.629 |
| III | 38 (20.4) | 11 (21.2) | 21 (21.6) | 0.670 | 6 (16.2) | 0.825 |
| IV | 83 (44.6) | 18 (34.6) | 45 (46.4) | 0.330 | 20 (54.1) | 0.168 |
| N/A | 17 (9.1) | 6 (11.5) | 4 (4.1) | 0.557 | 4 (10.8) | 1.000 |
Abbreviations: VTE, venous thromboembolism; N/A, not available; BMI, body mass index; SD, standard deviation.
✝
Including, but not limited to patients of Spanish origin.
Note: P-values compare characteristics of patients with cancer-associated VTE in Blacks vs Whites and Others vs Whites